Single Rising Dose Study of BI 135585 XX in Health Asian Male Volunteers.

NCT01291732 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Matching placebo
DRUG: BI 135585 XX

Sponsor

Boehringer Ingelheim